6mOpinion
Tomas J. Philipson: Donald Trump’s drug-pricing pressure is working — but it requires nuance
Drugmakers feel empowered to resist foreign price controls — confident that the Trump administration will have their backs.
Nearly 202 companies are announcing July-September quarter earnings for the ongoing financial year 2026 today.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback